Atlas Trials

A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults

Clinical trial NCT05517174 · COMPLETED

Trial details

NCT number
NCT05517174
Sponsor
Tor Biering-Sørensen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Influenza
Start date
2022-09-22
Primary completion
2025-05-31
Enrollment
332438

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.